Synopsis : Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a clinical-stage biopharmaceutical company pursuing novel therapeutics for fatty liver diseases, announced today that Dr. Dominic F.…
Tag:
Madrigal pharmaceuticals
-
-
RegulatoryU.S FDA
Positive Phase III Data Lifts Madrigal, Hopes for an Effective NASH Treatment
by adminby adminSynopsis : Shares of Madrigal Pharmaceuticals went up in premarket trading after the company announced positive topline data from its Phase III…